Harwood Feffer LLP Announces Investigation Of Gerber Scientific Inc.
Harwood Feffer LLP ( www.hfesq.com) is investigating potential claims against the board of directors of Gerber Scientific, Inc. (“Gerber”) (NYSE: GRB) concerning the proposed acquisition by Vector Capital Corporation (“Vector”).
Under the terms of the merger agreement, the shareholders of the Company will receive $11.00 per share in cash, or approximately $281.8 million in total. In addition to the cash payment, each shareholder of the Company will receive for each share they own a non-transferable right to receive contingent cash payments at future times, if recoveries are made pursuant to certain litigation claims in respect of a United States patent for computerized “print to cut” technology (U.S. Patent 5,537,135).
Our investigation concerns whether the board of directors has undertaken a fair process to obtain fair consideration for all shareholders of Gerber.
If you own shares of Gerber and would like to learn more about these claims or if you wish to discuss this matter and have any questions or information concerning this announcement, please contact Robert I. Harwood, Esq. at email@example.com or James G. Flynn, Esq. at firstname.lastname@example.org. You may also call them at (877) 935-7400. For more information about class actions, or to sign up online, please visit our website: www.hfesq.com.Harwood Feffer LLP is a national shareholder litigation firm. Harwood Feffer LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ( www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts